Dorsal Root Ganglion Stimulation (DRG) EPG
ABBOTT MEDICAL · Decision date Oct 28, 2026
What did the FDA decide?
The FDA record P150004/S101 is a 30-day notice for a process change involving manufacturer, sterilizer, packager, or supplier. Its stated purpose is qualification of an alternate antenna component used in Abbott's Spinal Cord Stimulators, Deep Brain Stimulators, and Dorsal Root Ganglion External Pulse Generators. The device category is a dorsal root ganglion stimulator for pain relief, product code PMP, under the original PMA P150004.
As a supplement, S101 does not constitute a new approval of the whole system; the notice describes a component and supplier process change. The source does not identify the antenna's material, function, or the specific supplier, and the reported purpose is not independent proof of safety or clinical effectiveness. The decision code OK30 is not explained in the supplied fields.
FDA approval order statement
qualification of an alternate antenna component utilized in Abbott's Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), and Dorsal Root Ganglion (DRG) External Pulse Generators (EPG)
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Oct 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150004/S101
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- PMP
- Decision code
- OK30
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dorsal root ganglion stimulator for pain relief.
- Applicant
- Abbott Medical
- Product code
- PMP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150004 · Original PMA
Axium Neurostimulator System
P150004/S100 · Related supplement
Proclaim DRG IPG
P150004/S101 received
Application receipt date recorded by FDA.
P150004/S101 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P150004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Axium Neurostimulator SystemP150004 | ABBOTT MEDICAL | PMA approval | Feb 11, 2016 | FDA |
Proclaim DRG IPGP150004/S100 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Preston Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P150004/S101
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
